Woods K L, Linton S P, Kendall M J, Faragher E B, Grieve R J
Eur J Clin Pharmacol. 1979 May 21;15(4):229-33. doi: 10.1007/BF00618510.
The effects of intravenous propranolol, metoprolol, acebutolol and placebo on exercise-induced changes in heart rate and peak flow rate (PFR) have been studied in a group of healthy subjects. The three beta-blockers produced significant and comparable reductions in exercise-induced tachycardia and the magnitude of the reduction was related to the log plasma concentration of each drug. Significant cardiac beta-blockade was detectable for three hours after giving propranolol and for four hours after metoprolol and acebutolol. The exercise-induced changes in PFR were small and variable and were not significantly affected by any of the drugs. We conclude that, contrary to published reports, exercise-induced changes in heart rate and PFR in healthy subjects do not provide a satisfactory test system for assessing the selectivity of beta-blockers.
在一组健康受试者中,研究了静脉注射普萘洛尔、美托洛尔、醋丁洛尔和安慰剂对运动诱发的心率和峰值流速(PFR)变化的影响。三种β受体阻滞剂在运动诱发的心动过速方面产生了显著且相当的降低,降低幅度与每种药物的血浆浓度对数相关。给予普萘洛尔后三小时以及给予美托洛尔和醋丁洛尔后四小时,可检测到显著的心脏β受体阻滞。运动诱发的PFR变化较小且不稳定,且未受到任何一种药物的显著影响。我们得出结论,与已发表的报告相反,健康受试者中运动诱发的心率和PFR变化并不能为评估β受体阻滞剂的选择性提供一个令人满意的测试系统。